Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finn Wisløff

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 30, 2010
[Leadership and academic competence]Erlend B Smeland, Frode Vartdal, Finn Wisløff
Clinical Nutrition (Edinburgh, Scotland)|January 2, 2010
Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell supportPer Ole Iversen, Finn Wisløff, Nina Gulbrandsen
Thrombosis Research|April 5, 2003
Laboratory diagnosis of the antiphospholipid syndromeFinn Wisløff, Eva M Jacobsen, Sigurd Liestøl
Thrombosis Research|April 18, 2002
Dilute prothrombin time-based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastinSigurd Liestøl, Eva Marie Jacobsen, Finn Wisløff
European Journal of Haematology|February 14, 2004
Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differencesNina Gulbrandsen, Marianne J Hjermstad, Finn Wisløff, et al.
Health and Quality of Life Outcomes|August 4, 2010
Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myelomaAnn K Kvam, Finn Wisløff, Peter M Fayers
European Journal of Haematology|October 14, 2006
Serum calcium is an independent predictor of quality of life in multiple myelomaFinn Wisløff, Ann Kristin Kvam, Martin Hjorth, et al.
Thrombosis Journal|January 27, 2006
Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybreneEva M Jacobsen, Elin J Trettenes, Finn Wisløff, et al.
European Journal of Haematology|September 9, 2005
Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changesFinn Wisløff, Nina Gulbrandsen, Martin Hjorth, et al.
British Journal of Haematology|November 10, 2006
Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulantsSigurd Liestøl, Per Morten Sandset, Eva Marie Jacobsen, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 30, 2010
[Leadership and academic competence]Erlend B Smeland, Frode Vartdal, Finn Wisløff
Clinical Nutrition (Edinburgh, Scotland)|January 2, 2010
Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell supportPer Ole Iversen, Finn Wisløff, Nina Gulbrandsen
Thrombosis Research|April 5, 2003
Laboratory diagnosis of the antiphospholipid syndromeFinn Wisløff, Eva M Jacobsen, Sigurd Liestøl
Thrombosis Research|April 18, 2002
Dilute prothrombin time-based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastinSigurd Liestøl, Eva Marie Jacobsen, Finn Wisløff
European Journal of Haematology|February 14, 2004
Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differencesNina Gulbrandsen, Marianne J Hjermstad, Finn Wisløff, et al.
Health and Quality of Life Outcomes|August 4, 2010
Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myelomaAnn K Kvam, Finn Wisløff, Peter M Fayers
European Journal of Haematology|October 14, 2006
Serum calcium is an independent predictor of quality of life in multiple myelomaFinn Wisløff, Ann Kristin Kvam, Martin Hjorth, et al.
Thrombosis Journal|January 27, 2006
Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybreneEva M Jacobsen, Elin J Trettenes, Finn Wisløff, et al.
European Journal of Haematology|September 9, 2005
Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changesFinn Wisløff, Nina Gulbrandsen, Martin Hjorth, et al.
British Journal of Haematology|November 10, 2006
Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulantsSigurd Liestøl, Per Morten Sandset, Eva Marie Jacobsen, et al.
Pageof 3